Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats

Regulatory Peptides

Volumn 178, Issue 1-3, 2012, Pages 43-50

  Najafipour, Hamid ^a   Soltani Hekmat, Ava ^a   Nekooian, Ali Akbar ^b   Esmaeili Mahani, Saeed ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Apelin; Blood pressure; Cardiac contractility; Gene expression; Reno vascular hypertension

Indexed keywords

ALDOSTERONE; APELIN RECEPTOR; ARGIPRESSIN;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APELIN RECEPTOR GENE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HYPERTENSION; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; GENE EXPRESSION; HYPERTENSION, RENOVASCULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIA; KIDNEY; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; STIMULATION, CHEMICAL; VENTRICULAR PRESSURE;

RATTUS;

EID: 84865378247     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.06.006     Document Type: Article

References (33)

1. Hall J.E., Guyton A.C. Textbook of medical physiology 2011, 227. Saunders Co, Philadelphia, Philadelphia, Pa.
2. Kagiyama S., Varela A., Phillips M.I., Galli S.M. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension 2001, 37:371-375.
3. Antonaccio M.J., Rubin B., Horovitz Z.P. Effects of captopril in animal models of hypertension. Clin Exp Hypertens 1980, 2(3-4):613-637.
4. Sadjadi J., Puttaparthi K., Welborn M.B., Rogers T.E., Moe O., Clagett G.P., Turnage R.H., Levi M., Modrall J.G. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic reno-vascular hypertension. J Vasc Surg 2002, 36(2):386-392.
5. Lee D.K., Cheng R., Nguyen T., T.Fan, Kariyawasam A.P., Liu Y., Osmond D.H., George S.R., O'Dowd B.F. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000, 74(1):34-41.
6. Szokodi I., Tavi P., Földes G., Voutilainen-Myllylä S., Ilves M., Tokola H., Pikkarainen S., Piuhola J., Rysä J., Tóth M., Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002, 91(5):434-440.
7. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., Nishizawa N., Kitada C., Onda H., Nishimura O., Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001, 1538(2-3):162-171.
8. O'Carroll A.M., Selby T.L., Palkovits M., Lolait S.J. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000, 1492(1):72-80.
9. Ashley E., Chun H.J., Quertermous T. Opposing cardiovascular roles for the angiotensin and apelin signaling pathways. J Mol Cell Cardiol 2006, 41:778-781.
10. Barnes G., Japp A.G., Newby D.E. Translational promise of the apelin-APJ system. Heart 2010, 96(13):1011-1016.
11. Reaux A., Gallatz K., Palkovits M., Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002, 113(3):653-662.
12. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001, 99(2-3):87-92.
13. Seyedabadi M., Goodchild A.K., Pilowsky P.M. Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Auton Neurosci 2002, 101(1-2):32-38.
14. Chandrasekaran B., Dar O., McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 2008, 10(8):725-732.
15. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., Deng A., Eichhorn J., Mahajan R., Agrawal R., Greve J., Robbins R., Patterson A.J., Bernstein D., Quertermous T. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005, 65(1):73-82.
16. Hus-Citharel A., Bouby N., Frugiere A., Bodineau L., Gasc J.M., Llorens-Cortes C. Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 2008, 74(4):486-494.
17. Ladeiras-Lopes R., Ferreira-Martins J., Leite-Moreira A.F. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol 2008, 90(5):343-349.
18. Soltani Hekmat A., Najafipour H., Nekooian A.A., Esmaeli-Mahani S., Javanmardi K. Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys. Regul Pept 2011, 172(1-3):62-68.
19. Silva G.B., Garvin J.L. Rac1 mediates NaCl-induced superoxide generation in the thick ascending limb. Am J Physiol Renal Physiol 2010, 298(2):421-425.
20. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.A., Struhl K. Short protocols in molecular biology 2002, Wiley, USA.
21. Hajializadeh Z., Esmaeili-Mahani S., Sheibani V., Kaeidi A., Atapour M., Abbasnejad M. Changes in the gene expression of specific G-protein subunits correlate with morphine insensitivity in streptozotocin-induced diabetic rats. Neuropeptides 2010, 44(4):299-304.
22. Japp A.G., Newby D.E. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 2008, 75(10):1882-1892.
23. Foldes G., Horkay F., Szokodi I., Vuolteenaho O., Ilves M., Lindstedt K.A., Mayranpaa M., Sarman B., Seres L., Skoumal R., Lako-Futo Z., deChatel R., Ruskoaho H., Toth M. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003, 308(3):480-485.
24. Zhong J.C., Huang D.Y., Liu G.F., Jin H.Y., Yang Y.M., Li Y.F., Song X.H., Du K. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 2005, 65(3):743-750.
25. Zile M.R., Gaasch W.H., Carroll J.D., Feldman M.D., Aurigemma G.P., Schaer G.L., Ghali J.K., Liebson P.R. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?. Circulation 2001, 104(7):779-782.
26. Berry M.F., Pirolli T.J., Jayasankar V., Burdick J., Morine K.J., Gardner T.J., Woo Y.J. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004, 110:187-193.
27. Jia Y.X., Lu Z.F., Zhang J., Pan C.S., Yang J.H., Zhao J., Yu F., Duan X.H., Tang C.S., Qi Y.F. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept 2006, 133(1-3):147-154.
28. Iwanaga Y., Kihara Y., Takenaka H., Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 2006, 41(5):798-806.
29. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension 1991, 17(5):707-719.
30. Brailoiu G.C., Dun S.L., Yang J., Ohsawa M., Chang J.K., Dun N.J. Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 2002, 327(3):193-197.
31. De Mota N., Reaux-Le Goazigo A., El Messari S., Chartrel N., Roesch D., Dujardin C., Kordon C., Vaudry H., Moos F., Llorens-Cortes C. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A 2004, 101(28):10464-10469.
32. Charles C.J., Rademaker M.T., Richards A.M. Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep. J Endocrinol 2006, 189(3):701-710.
33. Newson M.J., Roberts E.M., Pope G.R., Lolait S.J., O'Carroll A.M. The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms. J Endocrinol 2009, 202(1):123-129.